OM1 Stock

Healthcare Technology Company

Sign up today and learn more about OM1 Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

General Catalyst Partners


Boston MA, US

Total Funding


About OM1 Stock

OM1 (formerly Better Outcomes) is a digital health company focused on the measurement, comparison, and prediction of treatment outcomes. OM1 believes that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. OM1 offers a real-world evidence platform, clinical registries and AI technologies that aim to help clients with their research, to measure and benchmark health outcomes and to personalize patient care. 

OM1 was founded in 2015 by Richard Gliklich and is headquartered in Boston, Massachusetts. Notable investors include General Catalyst, Polaris Partners, and Scale Venture Partners.


Funding History

September 2015$1.3M
September 2015$4.0M
July 2016$14.9M
April 2018$21.0M
October 2019$50.0M
July 2021$85.0M


Chief Executive Officer

Rich Gliklich

Chief Financial Officer

Dennis Reilly


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: